Chemocentryx Stock Z Score
CCXIDelisted Stock | USD 51.99 0.00 0.00% |
ChemoCentryx |
ChemoCentryx Company Z Score Analysis
ChemoCentryx's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current ChemoCentryx Z Score | 19.1 |
Most of ChemoCentryx's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChemoCentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, ChemoCentryx has a Z Score of 19.1. This is 182.96% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The z score for all United States stocks is 119.04% lower than that of the firm.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
ChemoCentryx Fundamentals
Return On Equity | -46.96 | |||
Return On Asset | -18.55 | |||
Operating Margin | (353.17) % | |||
Current Valuation | 3.45 B | |||
Shares Outstanding | 70.03 M | |||
Shares Owned By Insiders | 12.01 % | |||
Shares Owned By Institutions | 84.39 % | |||
Number Of Shares Shorted | 7.61 M | |||
Price To Earning | 40.53 X | |||
Price To Book | 10.04 X | |||
Price To Sales | 97.66 X | |||
Revenue | 37.28 M | |||
Gross Profit | (51.07 M) | |||
EBITDA | (127.6 M) | |||
Net Income | (133.09 M) | |||
Cash And Equivalents | 328.62 M | |||
Cash Per Share | 4.61 X | |||
Total Debt | 73.2 M | |||
Debt To Equity | 0.31 % | |||
Current Ratio | 4.54 X | |||
Book Value Per Share | 5.18 X | |||
Cash Flow From Operations | (53.5 M) | |||
Short Ratio | 4.89 X | |||
Earnings Per Share | (0.94) X | |||
Number Of Employees | 178 | |||
Beta | 1.23 | |||
Market Capitalization | 3.64 B | |||
Total Asset | 78.16 M | |||
Retained Earnings | (441.3 M) | |||
Working Capital | 66.54 M | |||
Current Asset | 72.03 M | |||
Current Liabilities | 5.49 M | |||
Z Score | 19.1 |
About ChemoCentryx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChemoCentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChemoCentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChemoCentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with ChemoCentryx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChemoCentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoCentryx will appreciate offsetting losses from the drop in the long position's value.Moving together with ChemoCentryx Stock
0.83 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
0.83 | NONOF | Novo Nordisk AS | PairCorr |
Moving against ChemoCentryx Stock
0.76 | WXIBF | WuXi Biologics | PairCorr |
0.76 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
0.64 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
0.56 | CSLLY | CSL | PairCorr |
0.52 | CMXHF | CSL Limited | PairCorr |
The ability to find closely correlated positions to ChemoCentryx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChemoCentryx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChemoCentryx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChemoCentryx to buy it.
The correlation of ChemoCentryx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChemoCentryx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChemoCentryx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChemoCentryx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in ChemoCentryx Stock
If you are still planning to invest in ChemoCentryx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ChemoCentryx's history and understand the potential risks before investing.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |